L
L&C Bio Co Ltd
KOSDAQ:290650
L&C Bio Co Ltd
KOSDAQ:290650
Price:
95 900
KRW
3.34%
Market Closed
Market Cap:
₩2.4T
Balance Sheet
Balance Sheet Decomposition
L&C Bio Co Ltd
L&C Bio Co Ltd
Balance Sheet Decomposition is not available for
L&C Bio Co Ltd
L&C Bio Co Ltd
Balance Sheet
L&C Bio Co Ltd
L&C Bio Co Ltd
Currency: KRW
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
584
|
383
|
3 119
|
12 310
|
6 962
|
4 639
|
9 472
|
6 589
|
14 949
|
18 287
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
584
|
383
|
3 119
|
12 310
|
6 962
|
4 639
|
9 472
|
6 589
|
14 949
|
18 287
|
|
| Short-Term Investments |
0
|
3 494
|
3 461
|
24 274
|
21 951
|
22 705
|
2 238
|
5 725
|
44 243
|
5 851
|
|
| Total Receivables |
3 083
|
4 353
|
5 892
|
7 418
|
10 137
|
9 306
|
13 242
|
13 553
|
19 894
|
52 049
|
|
| Accounts Receivables |
2 925
|
4 295
|
5 533
|
7 071
|
9 054
|
9 159
|
12 751
|
13 216
|
18 721
|
21 794
|
|
| Other Receivables |
158
|
58
|
359
|
347
|
1 083
|
147
|
492
|
337
|
1 174
|
30 255
|
|
| Inventory |
3 889
|
5 143
|
5 372
|
5 581
|
6 230
|
8 085
|
12 312
|
34 203
|
46 288
|
46 779
|
|
| Other Current Assets |
51
|
213
|
211
|
324
|
812
|
765
|
2 459
|
4 211
|
4 982
|
7 223
|
|
| Total Current Assets |
7 606
|
13 586
|
18 054
|
49 906
|
46 090
|
45 501
|
47 632
|
64 284
|
130 357
|
130 189
|
|
| PP&E Net |
1 109
|
1 445
|
1 447
|
4 902
|
7 287
|
9 483
|
17 895
|
53 138
|
74 655
|
97 017
|
|
| PP&E Gross |
1 109
|
1 445
|
1 447
|
4 902
|
7 287
|
9 483
|
17 895
|
53 138
|
74 655
|
97 017
|
|
| Accumulated Depreciation |
725
|
972
|
1 238
|
1 126
|
2 341
|
3 868
|
6 385
|
10 460
|
13 849
|
16 516
|
|
| Intangible Assets |
39
|
109
|
93
|
87
|
218
|
215
|
1 150
|
1 255
|
1 456
|
1 932
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 320
|
0
|
197 307
|
|
| Note Receivable |
123
|
0
|
0
|
690
|
0
|
0
|
700
|
1 000
|
646
|
1 158
|
|
| Long-Term Investments |
108
|
151
|
289
|
0
|
9 602
|
22 433
|
36 754
|
75 768
|
47 254
|
31 373
|
|
| Other Long-Term Assets |
127
|
368
|
608
|
1 794
|
3 029
|
2 945
|
3 269
|
1 961
|
7 861
|
16 626
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 320
|
0
|
197 307
|
|
| Total Assets |
9 111
N/A
|
15 661
+72%
|
20 490
+31%
|
57 379
+180%
|
66 226
+15%
|
80 576
+22%
|
107 401
+33%
|
199 725
+86%
|
262 230
+31%
|
475 601
+81%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
965
|
348
|
282
|
238
|
191
|
266
|
1 021
|
2 910
|
1 745
|
2 331
|
|
| Accrued Liabilities |
163
|
58
|
45
|
63
|
107
|
137
|
164
|
332
|
468
|
816
|
|
| Short-Term Debt |
450
|
0
|
200
|
0
|
0
|
0
|
0
|
9 508
|
8 247
|
31 600
|
|
| Current Portion of Long-Term Debt |
454
|
542
|
263
|
0
|
169
|
370
|
733
|
1 134
|
72 469
|
68 263
|
|
| Other Current Liabilities |
420
|
1 233
|
2 495
|
2 760
|
2 933
|
2 902
|
3 717
|
4 855
|
18 909
|
51 699
|
|
| Total Current Liabilities |
2 452
|
2 181
|
3 284
|
3 060
|
3 401
|
3 675
|
5 635
|
18 738
|
101 838
|
154 708
|
|
| Long-Term Debt |
2 234
|
2 989
|
0
|
1 000
|
1 622
|
14 663
|
6 098
|
71 303
|
1 417
|
24 038
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
1 194
|
592
|
900
|
63
|
|
| Minority Interest |
0
|
0
|
0
|
337
|
2 087
|
3 446
|
8 245
|
9 869
|
9 911
|
10 372
|
|
| Other Liabilities |
512
|
472
|
394
|
519
|
932
|
985
|
1 208
|
1 271
|
1 219
|
2 067
|
|
| Total Liabilities |
5 198
N/A
|
5 641
+9%
|
3 678
-35%
|
4 916
+34%
|
8 043
+64%
|
22 769
+183%
|
22 380
-2%
|
101 773
+355%
|
115 285
+13%
|
191 248
+66%
|
|
| Equity | |||||||||||
| Common Stock |
1 268
|
1 318
|
1 493
|
3 617
|
3 680
|
10 985
|
11 388
|
11 388
|
11 388
|
11 388
|
|
| Retained Earnings |
2 533
|
4 551
|
8 446
|
13 654
|
20 746
|
20 639
|
33 342
|
36 865
|
83 593
|
222 197
|
|
| Additional Paid In Capital |
112
|
3 761
|
6 858
|
35 172
|
35 500
|
30 659
|
43 875
|
51 988
|
51 994
|
51 990
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
1 038
|
2 201
|
337
|
1 738
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
4 310
|
6 358
|
6 358
|
3 890
|
3 873
|
|
| Other Equity |
0
|
390
|
17
|
19
|
1 742
|
166
|
1 735
|
1 868
|
3 523
|
4 389
|
|
| Total Equity |
3 913
N/A
|
10 020
+156%
|
16 813
+68%
|
52 463
+212%
|
58 183
+11%
|
57 806
-1%
|
85 021
+47%
|
97 952
+15%
|
146 945
+50%
|
284 353
+94%
|
|
| Total Liabilities & Equity |
9 111
N/A
|
15 661
+72%
|
20 490
+31%
|
57 379
+180%
|
66 226
+15%
|
80 576
+22%
|
107 401
+33%
|
199 725
+86%
|
262 230
+31%
|
475 601
+81%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
15
|
16
|
18
|
22
|
22
|
22
|
23
|
23
|
23
|
23
|
|
Switch to:
Switch to:
See Also
Discover More
